[HTML][HTML] Effectiveness of mRNA-1273 and BNT162b2 vaccines in Qatar
LJ Abu-Raddad, H Chemaitelly… - New England Journal of …, 2022 - Mass Medical Soc
LJ Abu-Raddad, H Chemaitelly, R Bertollini
New England Journal of Medicine, 2022•Mass Medical SocCovid-19 Vaccine Effectiveness in Qatar In two matched retrospective cohort studies
comparing BNT162b2 and mRNA-1273 Covid-19 vaccines (> 190,000 recipients each),
both were highly effective at preventing hospitalization and death. The incidence of
breakthrough infections was lower among mRNA-1273–vaccinated persons (0.59%; 95%
CI, 0.55 to 0.64) than among BNT162b2-vaccinated persons (0.84%; 95% CI, 0.79 to 0.89).
comparing BNT162b2 and mRNA-1273 Covid-19 vaccines (> 190,000 recipients each),
both were highly effective at preventing hospitalization and death. The incidence of
breakthrough infections was lower among mRNA-1273–vaccinated persons (0.59%; 95%
CI, 0.55 to 0.64) than among BNT162b2-vaccinated persons (0.84%; 95% CI, 0.79 to 0.89).
Covid-19 Vaccine Effectiveness in Qatar
In two matched retrospective cohort studies comparing BNT162b2 and mRNA-1273 Covid-19 vaccines (>190,000 recipients each), both were highly effective at preventing hospitalization and death. The incidence of breakthrough infections was lower among mRNA-1273–vaccinated persons (0.59%; 95% CI, 0.55 to 0.64) than among BNT162b2-vaccinated persons (0.84%; 95% CI, 0.79 to 0.89).
The New England Journal Of Medicine